You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

SONIDEGIB PHOSPHATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for sonidegib phosphate and what is the scope of patent protection?

Sonidegib phosphate is the generic ingredient in one branded drug marketed by Sun Pharm and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sonidegib phosphate has one hundred and eighteen patent family members in forty-nine countries.

There is one drug master file entry for sonidegib phosphate. One supplier is listed for this compound.

Summary for SONIDEGIB PHOSPHATE
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for SONIDEGIB PHOSPHATE
Generic Entry Date for SONIDEGIB PHOSPHATE*:
Constraining patent/regulatory exclusivity:
Dosage:
CAPSULE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for SONIDEGIB PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Senhwa Biosciences, Inc.Phase 1
Novartis PharmaceuticalsPhase 2
National Cancer Institute (NCI)Phase 2

See all SONIDEGIB PHOSPHATE clinical trials

Pharmacology for SONIDEGIB PHOSPHATE

US Patents and Regulatory Information for SONIDEGIB PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm ODOMZO sonidegib phosphate CAPSULE;ORAL 205266-001 Jul 24, 2015 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
Sun Pharm ODOMZO sonidegib phosphate CAPSULE;ORAL 205266-001 Jul 24, 2015 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Sun Pharm ODOMZO sonidegib phosphate CAPSULE;ORAL 205266-001 Jul 24, 2015 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SONIDEGIB PHOSPHATE

Country Patent Number Title Estimated Expiration
Ukraine 103049 СОЛІ N-[6-ЦИС-2,6-ДИМЕТИЛМОРФОЛІН-4-ІЛ)ПІРИДИН-3-ІЛ]-2-МЕТИЛ-4'-(ТРИФТОРМЕТОКСИ)[1,1'-ДИФЕНІЛ]-3-КАРБОКСАМІДУ[СОЛИ N-[6-ЦИС-2,6-ДИМЕТИЛМОРФОЛИН-4-ИЛ)ПИРИДИН-3-ИЛ]-2-МЕТИЛ-4'-(ТРИФТОРМЕТОКСИ)[1,1'-ДИФЕНИЛ]-3-КАРБОКСАМИДА (SALTS OF N-[6-CIS-2,6-DIMETHYLMORPHOLIN-4YL)PYRIDINE-3YL]-2-METHYL-4'-(TRIFLUOROMETHOXY)[1,1'-BIPHENYL]-3-CARBOXAMIDE) ⤷  Try a Trial
Argentina 060858 COMPUESTOS Y COMPOSICIONES COMO MODULADORES DE LA SENDA DE HEDGEHOG ⤷  Try a Trial
Russian Federation 2413718 СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ МОДУЛЯТОРОВ ПУТИ HEDGEHOG (COMPOUNDS AND COMPOSITIONS AS MODULATORS OF HEDGEHOG PATHWAY) ⤷  Try a Trial
South Korea 20120015363 SALTS OF N-[6-CIS-2,6-DIMETHYLMORPHOLIN-4-YL)PYRIDINE-3-YL]-2-METHYL-4'-(TRIFLUOROMETHOXY)[1,1'-BIPHENYL]-3-CARBOXAMIDE ⤷  Try a Trial
Taiwan I367883 ⤷  Try a Trial
China 102159570 Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide ⤷  Try a Trial
Brazil PI0918629 sal de n-[6-cis-2,6-dimetilmorfolin-4-il]piridina-3-il]-2-metil-4'-(trifluormetóxi)[1-1'-bifenil]-3-carboxcamida e composição farmacêutica ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for SONIDEGIB PHOSPHATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2021328 C02021328/01 Switzerland ⤷  Try a Trial VERTRETERLOESCHUNG
2021328 PA2015051 Lithuania ⤷  Try a Trial PRODUCT NAME: SONIDEGIBUM; REGISTRATION NO/DATE: EU/1/15/1030 20150818
2021328 300790 Netherlands ⤷  Try a Trial DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT
2021328 PA2015051,C2021328 Lithuania ⤷  Try a Trial PRODUCT NAME: SONIDEGIBAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, HIDRATAS ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/15/1030 20150818
2021328 15C0077 France ⤷  Try a Trial PRODUCT NAME: SONIDEGIB OU SEL,HYDRATE,OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1030 20150818
2021328 122016000001 Germany ⤷  Try a Trial PRODUCT NAME: SONIDEGIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ, HYDRAT ODER SOLVAT HIERVON; REGISTRATION NO/DATE: EU/1/15/1030 20150814
2021328 658 Finland ⤷  Try a Trial
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.